Jjsh personal page - To The Moon

Jjsh

Jjsh

No personal profile

94Follow

9Followers

1Topic

0Badge

03-18 08:57

$TSLA 20260318 397.5 PUT$ v

2022-04-18

👏🏻

Bed Bath & Beyond Stock Ready to Scale Into

03-18 07:47

$TSLA 20260318 397.5 PUT$ n

2025-06-05

$NEBIUS(NBIS)$ lucky

2022-04-28

$Tiger Brokers(TIGR)$🤔

2022-01-09

🤙🏻

3 COVID Stocks That Will Make Billions in 2022

2022-03-04

🤢

EV Stocks Slid in Premarket Trading

2025-09-06

$NVIDIA(NVDA)$ b

2022-07-28

$Apple(AAPL)$Ok

2022-05-19

$Tiger Brokers(TIGR)$Ok

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4087548065759240","uuid":"4087548065759240","gmtCreate":1624448402129,"gmtModify":1639533056816,"name":"Jjsh","pinyin":"jjsh","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":9,"headSize":94,"tweetSize":430,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":8,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.08.02","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.05.06","exceedPercentage":"93.37%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.46%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.08.02","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":16,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":543816353595464,"gmtCreate":1773795447841,"gmtModify":1773795450499,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087548065759240","authorIdStr":"4087548065759240"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/OPT/TSLA 20260318 397.5 PUT\">$TSLA 20260318 397.5 PUT$</a> v","listText":"<a href=\"https://ttm.financial/OPT/TSLA 20260318 397.5 PUT\">$TSLA 20260318 397.5 PUT$</a> v","text":"$TSLA 20260318 397.5 PUT$ v","images":[{"img":"https://community-static.tradeup.com/news/4e5415071839bb03a02177ec7702ac72","width":"924","height":"1536"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/543816353595464","isVote":1,"tweetType":1,"viewCount":28,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":543799259493704,"gmtCreate":1773791225985,"gmtModify":1773791228750,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087548065759240","authorIdStr":"4087548065759240"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/OPT/TSLA 20260318 397.5 PUT\">$TSLA 20260318 397.5 PUT$</a> n","listText":"<a href=\"https://ttm.financial/OPT/TSLA 20260318 397.5 PUT\">$TSLA 20260318 397.5 PUT$</a> n","text":"$TSLA 20260318 397.5 PUT$ n","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/543799259493704","isVote":1,"tweetType":1,"viewCount":88,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":512311824761368,"gmtCreate":1766103685994,"gmtModify":1766103688805,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087548065759240","authorIdStr":"4087548065759240"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> g","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> g","text":"$NVIDIA(NVDA)$ g","images":[{"img":"https://community-static.tradeup.com/news/ed1a2e534fea926304762ff0809bea88","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/512311824761368","isVote":1,"tweetType":1,"viewCount":952,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":509091190252104,"gmtCreate":1765321262772,"gmtModify":1765321266410,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087548065759240","authorIdStr":"4087548065759240"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> a","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> a","text":"$NVIDIA(NVDA)$ a","images":[{"img":"https://community-static.tradeup.com/news/45543545ee6e6bbfd73b79792aa28f66","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/509091190252104","isVote":1,"tweetType":1,"viewCount":1144,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":507959194415944,"gmtCreate":1765035188753,"gmtModify":1765035193250,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087548065759240","authorIdStr":"4087548065759240"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> h","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> h","text":"$NVIDIA(NVDA)$ h","images":[{"img":"https://community-static.tradeup.com/news/82c24a7b6a2b3ec8082b160f5bea78ef","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/507959194415944","isVote":1,"tweetType":1,"viewCount":999,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":503984060507080,"gmtCreate":1764066187708,"gmtModify":1764066191152,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087548065759240","authorIdStr":"4087548065759240"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> a","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> a","text":"$NVIDIA(NVDA)$ a","images":[{"img":"https://community-static.tradeup.com/news/5aead3f6823bfe1c10f4dbfa366a84f0","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/503984060507080","isVote":1,"tweetType":1,"viewCount":1100,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":502688668107480,"gmtCreate":1763735235793,"gmtModify":1763735239338,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087548065759240","authorIdStr":"4087548065759240"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> a","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> a","text":"$NVIDIA(NVDA)$ a","images":[{"img":"https://community-static.tradeup.com/news/d77c4fd0d042db962f4544ed9b528d36","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/502688668107480","isVote":1,"tweetType":1,"viewCount":826,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":497682558014408,"gmtCreate":1762527050153,"gmtModify":1762527053124,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087548065759240","authorIdStr":"4087548065759240"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a>&nbsp;","text":"$NVIDIA(NVDA)$","images":[{"img":"https://community-static.tradeup.com/news/8a30cf3d11da0c1e58dfde65228c4bc8","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/497682558014408","isVote":1,"tweetType":1,"viewCount":1649,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":493917467140184,"gmtCreate":1761607877844,"gmtModify":1761607880995,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087548065759240","authorIdStr":"4087548065759240"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> a","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> a","text":"$NVIDIA(NVDA)$ a","images":[{"img":"https://community-static.tradeup.com/news/19eeaa6318a7b5b3826645fb7d6436f3","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/493917467140184","isVote":1,"tweetType":1,"viewCount":1395,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":493917260558776,"gmtCreate":1761607831086,"gmtModify":1761607834595,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087548065759240","authorIdStr":"4087548065759240"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a>&nbsp;","text":"$NVIDIA(NVDA)$","images":[{"img":"https://community-static.tradeup.com/news/00b1fd947aaa5c02c6dde4426b9c5774","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/493917260558776","isVote":1,"tweetType":1,"viewCount":1332,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":493201880879936,"gmtCreate":1761433259355,"gmtModify":1761433262318,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087548065759240","authorIdStr":"4087548065759240"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> h","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> h","text":"$NVIDIA(NVDA)$ h","images":[{"img":"https://community-static.tradeup.com/news/eeef118bfd8926a726b1824e5ccfb5a3","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/493201880879936","isVote":1,"tweetType":1,"viewCount":1744,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":489347329982488,"gmtCreate":1760492836915,"gmtModify":1760492841729,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087548065759240","authorIdStr":"4087548065759240"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> a","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> a","text":"$NVIDIA(NVDA)$ a","images":[{"img":"https://community-static.tradeup.com/news/7818b3e9a05fdac02a1440774da683e9","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/489347329982488","isVote":1,"tweetType":1,"viewCount":1690,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":487192407040784,"gmtCreate":1759974048866,"gmtModify":1759974052138,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087548065759240","authorIdStr":"4087548065759240"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> a","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> a","text":"$NVIDIA(NVDA)$ a","images":[{"img":"https://community-static.tradeup.com/news/e7f364e312f23910e2533987d5620378","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/487192407040784","isVote":1,"tweetType":1,"viewCount":1096,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":483798290784336,"gmtCreate":1759145389164,"gmtModify":1759145392547,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087548065759240","authorIdStr":"4087548065759240"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$</a> a","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$</a> a","text":"$NVIDIA(NVDA)$ a","images":[{"img":"https://community-static.tradeup.com/news/d127ca559a66a37ce93a5c02a01db9ff","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/483798290784336","isVote":1,"tweetType":1,"viewCount":1198,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":481689538388232,"gmtCreate":1758634111827,"gmtModify":1758634115045,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087548065759240","authorIdStr":"4087548065759240"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> a","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> a","text":"$NVIDIA(NVDA)$ a","images":[{"img":"https://community-static.tradeup.com/news/9aa7e5aa13cca2dfe842c23d5f6c24a4","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/481689538388232","isVote":1,"tweetType":1,"viewCount":1301,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":480549587305368,"gmtCreate":1758345805451,"gmtModify":1758345808178,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087548065759240","authorIdStr":"4087548065759240"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> k","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> k","text":"$NVIDIA(NVDA)$ k","images":[{"img":"https://community-static.tradeup.com/news/2a279fc994ccc81aa7c470a1586427c1","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/480549587305368","isVote":1,"tweetType":1,"viewCount":919,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":477571300217712,"gmtCreate":1757600859391,"gmtModify":1757600862151,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087548065759240","authorIdStr":"4087548065759240"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> h","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> h","text":"$NVIDIA(NVDA)$ h","images":[{"img":"https://community-static.tradeup.com/news/0d1bdb0336f57bc7a971e6761d22c1b5","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/477571300217712","isVote":1,"tweetType":1,"viewCount":1388,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":475611224379424,"gmtCreate":1757143487275,"gmtModify":1757143490183,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087548065759240","authorIdStr":"4087548065759240"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> b","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> b","text":"$NVIDIA(NVDA)$ b","images":[{"img":"https://community-static.tradeup.com/news/61cf5a2bd17dc51e6a60fa4ce7e5f122","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":1,"link":"https://ttm.financial/post/475611224379424","isVote":1,"tweetType":1,"viewCount":736,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":472620431463296,"gmtCreate":1756421621623,"gmtModify":1756421624273,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087548065759240","authorIdStr":"4087548065759240"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> h","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> h","text":"$NVIDIA(NVDA)$ h","images":[{"img":"https://community-static.tradeup.com/news/e6ee4ad3f66d53f0863ee524ef84d00b","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/472620431463296","isVote":1,"tweetType":1,"viewCount":1372,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":469286645363296,"gmtCreate":1755573281692,"gmtModify":1755573284406,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087548065759240","authorIdStr":"4087548065759240"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> j","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> j","text":"$NVIDIA(NVDA)$ j","images":[{"img":"https://community-static.tradeup.com/news/8c383e2b011c306fa97fb31174e40cb2","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/469286645363296","isVote":1,"tweetType":1,"viewCount":1240,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"hots":[{"id":543816353595464,"gmtCreate":1773795447841,"gmtModify":1773795450499,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087548065759240","idStr":"4087548065759240"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/OPT/TSLA 20260318 397.5 PUT\">$TSLA 20260318 397.5 PUT$</a> v","listText":"<a href=\"https://ttm.financial/OPT/TSLA 20260318 397.5 PUT\">$TSLA 20260318 397.5 PUT$</a> v","text":"$TSLA 20260318 397.5 PUT$ v","images":[{"img":"https://community-static.tradeup.com/news/4e5415071839bb03a02177ec7702ac72","width":"924","height":"1536"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/543816353595464","isVote":1,"tweetType":1,"viewCount":28,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9081794608,"gmtCreate":1650276387288,"gmtModify":1676534684416,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087548065759240","idStr":"4087548065759240"},"themes":[],"htmlText":"&nbsp;👏🏻","listText":"&nbsp;👏🏻","text":"👏🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9081794608","repostId":"1120530029","repostType":4,"repost":{"id":"1120530029","kind":"news","pubTimestamp":1650275444,"share":"https://ttm.financial/m/news/1120530029?lang=en_US&edition=fundamental","pubTime":"2022-04-18 17:50","market":"us","language":"en","title":"Bed Bath & Beyond Stock Ready to Scale Into","url":"https://stock-news.laohu8.com/highlight/detail?id=1120530029","media":"marketbeat","summary":"Home goods retailer Bed Bath Beyond (NASDAQ: BBBY)stock has collapsed on its fiscal Q4 2021 earnings","content":"<html><head></head><body><p>Home goods retailer <b>Bed Bath Beyond (NASDAQ: BBBY)</b>stock has collapsed on its fiscal Q4 2021 earnings massive shortfall. The former high-flying meme stock blamed the lack of inventory and rising supply chain costs as the key headwinds that spoiled the party. Freight and shipping costs inflation also hit margins by 170 bps.  Its buybuy Baby subsidiary did manage to deliver on its $1.4 billion 2021 sales goal. Management presented a gloomy picture of devastating macroeconomic headwinds ranging from the ravaged global supply chain, ongoing effects from the Omicron variant, skyrocketing inflation, rising interest rates, geopolitical strife and uncertainty having an impact on consumer confidence and hurting sales. Shares received a momentary glimmer of hope when they spiked up to a high of $28.78 on news of activist investor and 9.8% beneficial owner Ryan Cohen’s RC Ventures entering into a cooperation agreement to gain three board seats and joining a Strategy Committee to explore strategic alternatives to unlock value. However, that pop was short-lived as shares collapsed to $15.74 on its fiscal Q4 2021 earnings release. The new Board of Directors will temporarily expand to 14 members following its Annual Meeting. Prudent investors seeking to gain exposure ahead of are bound can watch for opportunistic pullbacks in shares of Bed Bath &amp; Beyond.</p><p><b>Q4 FY Fiscal 2021 Earnings Release</b></p><p>On April 13, 2022, Bed Bath &amp; Beyond released its fourth-quarter fiscal 2021 results for the quarter ending February 2022. The Company reported an earnings-per-share (EPS) loss of (-$0.92) excluding non-recurring items versus consensus analyst estimates for a loss of (-$0.03), a (-$0.95) miss. The Company blamed shortfalls on supply chain challenges. Revenues fell (-21.7%) year-over-year (YoY) to $2.05 billion, missing consensus analyst estimates for $2.08 billion. Bed Bath &amp; Beyond CEO Mark Tritton commented, “We are disappointed that our sales and gross margin performance does not reflect our team&#39;s hard work and execution against both strategic and transformation efforts in 2021.  Macroeconomic factors, such as the disruption of the global supply chain, the Omicron variant, as well as the geopolitical turbulence weighing on consumer confidence, have uncovered more vulnerabilities than we could have foreseen at this stage of our transformation, as we completely rebuild the foundation of our business. The lack of available inventory to sell proved to be a continuing impediment to sales through the remainder of the fourth quarter and into the early part of fiscal 2022.  Specifically, despite our overall inventory levels, product in transit, not available for sale or held at port remained abnormally high, particularly in key items.  We estimate an impact of approximately $175 million to our fourth-quarter sales, or a high-single digit deficit, as a result of a lack of in-stock availability in our Bed Bath banner.&#34;</p><p><b>CEO Commentary</b></p><p>Bed Bath &amp; Beyond CEO Mark Britton set the tone with the disappointing performance placing blame mostly on rising supply chain costs leading to a shortage of inventory. Their not-available-to-sell inventory remained around 30% across key categories despite the Company’s initial projections to return to normal in Q4. Major items that were promoted in advertisements become out-of-stock quickly. He painted a gloomy narrative of extraordinary macroeconomic conditions including the derailing of the global supply chain, continued effects from COVID, inflation, rising interest rates and geopolitical tensions impacting consumer behavior.  Rising supply chain costs led to Q4 2021 comparable sales of (-12%) and adjusted gross margins of 28.8%. February 2022 industry trends continued to worsen due to macro market volatility. Escalating freight and shipping costs cut into margins, which would have been 32.4%. The Company initiated remodeling 131 stores and completed 80 stores while closing down over 200 underperforming stores. Key focus areas for the year will be inventory, pricing, and traffic. The Company also plans to launch a new loyalty program this year.</p><p><img src=\"https://static.tigerbbs.com/7f5bb44097e793ef1cb75b3415b108f9\" tg-width=\"1200\" tg-height=\"1158\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><p><b>BBBY Opportunistic Pullback Price Levels</b></p><p>Using the rifle charts on the weekly and daily time frames provides a precision view of the landscape for BBBY stock. The weekly rifle chart bottomed out on earnings at the $15.74<b>Fibonacci (fib) level</b>. The weekly rifle chart uptrend stalled as shares dropped sharply on the earnings. The weekly 50-period moving average (MA) resistance sits at $21.66. The weekly 5-period MA is sloping down at $20.86 as 15-period MA flattens at $17.42. The weekly 200-period MA sits at $16.91. The weekly stochastic peaked and is crossing back down at the 50-band. The weekly <b>market structure low (MSL)</b>buy triggers on a breakout above $18.04. The daily rifle chart has a downtrend with a falling 5-period MA at $18.36 and 50-period MA at $19.20. The daily 200-period MA resistance is at $20.64 and 15-period MA is falling at $21.48. The daily lower Bollinger Bands (BBs) sit at $15.20. The daily stochastic is smothered under the 10-band as it attempts to cross back up.<b>Prudent investors can watch for opportunistic pullback levels at the $15.74 fib, $$14.88, $13.75 fib, $12.84 fib, $12.39, $11.78 fib, $10.92 fib, and the $9.99 fib level. Upside trajectories range from the $21.06 fib level to the $27.54 fib level.</b></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bed Bath & Beyond Stock Ready to Scale Into</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBed Bath & Beyond Stock Ready to Scale Into\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-18 17:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketbeat.com/originals/bed-bath-and-beyond-stock-ready-to-scale-into/><strong>marketbeat</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Home goods retailer Bed Bath Beyond (NASDAQ: BBBY)stock has collapsed on its fiscal Q4 2021 earnings massive shortfall. The former high-flying meme stock blamed the lack of inventory and rising supply...</p>\n\n<a href=\"https://www.marketbeat.com/originals/bed-bath-and-beyond-stock-ready-to-scale-into/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BBBY":"Bed Bath & Beyond, Inc."},"source_url":"https://www.marketbeat.com/originals/bed-bath-and-beyond-stock-ready-to-scale-into/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1120530029","content_text":"Home goods retailer Bed Bath Beyond (NASDAQ: BBBY)stock has collapsed on its fiscal Q4 2021 earnings massive shortfall. The former high-flying meme stock blamed the lack of inventory and rising supply chain costs as the key headwinds that spoiled the party. Freight and shipping costs inflation also hit margins by 170 bps.  Its buybuy Baby subsidiary did manage to deliver on its $1.4 billion 2021 sales goal. Management presented a gloomy picture of devastating macroeconomic headwinds ranging from the ravaged global supply chain, ongoing effects from the Omicron variant, skyrocketing inflation, rising interest rates, geopolitical strife and uncertainty having an impact on consumer confidence and hurting sales. Shares received a momentary glimmer of hope when they spiked up to a high of $28.78 on news of activist investor and 9.8% beneficial owner Ryan Cohen’s RC Ventures entering into a cooperation agreement to gain three board seats and joining a Strategy Committee to explore strategic alternatives to unlock value. However, that pop was short-lived as shares collapsed to $15.74 on its fiscal Q4 2021 earnings release. The new Board of Directors will temporarily expand to 14 members following its Annual Meeting. Prudent investors seeking to gain exposure ahead of are bound can watch for opportunistic pullbacks in shares of Bed Bath & Beyond.Q4 FY Fiscal 2021 Earnings ReleaseOn April 13, 2022, Bed Bath & Beyond released its fourth-quarter fiscal 2021 results for the quarter ending February 2022. The Company reported an earnings-per-share (EPS) loss of (-$0.92) excluding non-recurring items versus consensus analyst estimates for a loss of (-$0.03), a (-$0.95) miss. The Company blamed shortfalls on supply chain challenges. Revenues fell (-21.7%) year-over-year (YoY) to $2.05 billion, missing consensus analyst estimates for $2.08 billion. Bed Bath & Beyond CEO Mark Tritton commented, “We are disappointed that our sales and gross margin performance does not reflect our team's hard work and execution against both strategic and transformation efforts in 2021.  Macroeconomic factors, such as the disruption of the global supply chain, the Omicron variant, as well as the geopolitical turbulence weighing on consumer confidence, have uncovered more vulnerabilities than we could have foreseen at this stage of our transformation, as we completely rebuild the foundation of our business. The lack of available inventory to sell proved to be a continuing impediment to sales through the remainder of the fourth quarter and into the early part of fiscal 2022.  Specifically, despite our overall inventory levels, product in transit, not available for sale or held at port remained abnormally high, particularly in key items.  We estimate an impact of approximately $175 million to our fourth-quarter sales, or a high-single digit deficit, as a result of a lack of in-stock availability in our Bed Bath banner.\"CEO CommentaryBed Bath & Beyond CEO Mark Britton set the tone with the disappointing performance placing blame mostly on rising supply chain costs leading to a shortage of inventory. Their not-available-to-sell inventory remained around 30% across key categories despite the Company’s initial projections to return to normal in Q4. Major items that were promoted in advertisements become out-of-stock quickly. He painted a gloomy narrative of extraordinary macroeconomic conditions including the derailing of the global supply chain, continued effects from COVID, inflation, rising interest rates and geopolitical tensions impacting consumer behavior.  Rising supply chain costs led to Q4 2021 comparable sales of (-12%) and adjusted gross margins of 28.8%. February 2022 industry trends continued to worsen due to macro market volatility. Escalating freight and shipping costs cut into margins, which would have been 32.4%. The Company initiated remodeling 131 stores and completed 80 stores while closing down over 200 underperforming stores. Key focus areas for the year will be inventory, pricing, and traffic. The Company also plans to launch a new loyalty program this year.BBBY Opportunistic Pullback Price LevelsUsing the rifle charts on the weekly and daily time frames provides a precision view of the landscape for BBBY stock. The weekly rifle chart bottomed out on earnings at the $15.74Fibonacci (fib) level. The weekly rifle chart uptrend stalled as shares dropped sharply on the earnings. The weekly 50-period moving average (MA) resistance sits at $21.66. The weekly 5-period MA is sloping down at $20.86 as 15-period MA flattens at $17.42. The weekly 200-period MA sits at $16.91. The weekly stochastic peaked and is crossing back down at the 50-band. The weekly market structure low (MSL)buy triggers on a breakout above $18.04. The daily rifle chart has a downtrend with a falling 5-period MA at $18.36 and 50-period MA at $19.20. The daily 200-period MA resistance is at $20.64 and 15-period MA is falling at $21.48. The daily lower Bollinger Bands (BBs) sit at $15.20. The daily stochastic is smothered under the 10-band as it attempts to cross back up.Prudent investors can watch for opportunistic pullback levels at the $15.74 fib, $$14.88, $13.75 fib, $12.84 fib, $12.39, $11.78 fib, $10.92 fib, and the $9.99 fib level. Upside trajectories range from the $21.06 fib level to the $27.54 fib level.","news_type":1,"symbols_score_info":{"BBBY":0.9}},"isVote":1,"tweetType":1,"viewCount":1261,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":543799259493704,"gmtCreate":1773791225985,"gmtModify":1773791228750,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087548065759240","idStr":"4087548065759240"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/OPT/TSLA 20260318 397.5 PUT\">$TSLA 20260318 397.5 PUT$</a> n","listText":"<a href=\"https://ttm.financial/OPT/TSLA 20260318 397.5 PUT\">$TSLA 20260318 397.5 PUT$</a> n","text":"$TSLA 20260318 397.5 PUT$ n","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/543799259493704","isVote":1,"tweetType":1,"viewCount":88,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":442858495279456,"gmtCreate":1749130853045,"gmtModify":1749130857716,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087548065759240","idStr":"4087548065759240"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NBIS\">$NEBIUS(NBIS)$</a> lucky","listText":"<a href=\"https://ttm.financial/S/NBIS\">$NEBIUS(NBIS)$</a> lucky","text":"$NEBIUS(NBIS)$ lucky","images":[{"img":"https://community-static.tradeup.com/news/b36ddde2f09298a711f611f7f37ed2ed","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":1,"link":"https://ttm.financial/post/442858495279456","isVote":1,"tweetType":1,"viewCount":1752,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9060620020,"gmtCreate":1651141327186,"gmtModify":1676534857805,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087548065759240","idStr":"4087548065759240"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a>🤔","listText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a>🤔","text":"$Tiger Brokers(TIGR)$🤔","images":[{"img":"https://community-static.tradeup.com/news/91509b2775f7ce8377b264ef9b52446b","width":"828","height":"1632"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9060620020","isVote":1,"tweetType":1,"viewCount":887,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9006637218,"gmtCreate":1641704917697,"gmtModify":1676533641663,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087548065759240","idStr":"4087548065759240"},"themes":[],"htmlText":"🤙🏻","listText":"🤙🏻","text":"🤙🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006637218","repostId":"1134509683","repostType":4,"repost":{"id":"1134509683","kind":"news","pubTimestamp":1641612579,"share":"https://ttm.financial/m/news/1134509683?lang=en_US&edition=fundamental","pubTime":"2022-01-08 11:29","market":"us","language":"en","title":"3 COVID Stocks That Will Make Billions in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1134509683","media":"Motley Fool","summary":"These three COVID-19 stocks could rake in a tremendous amount of cash this year.","content":"<html><head></head><body><p>It&#39;s a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.</p><p><b>Pfizer</b>(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy <b>Novavax</b>(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in <b>Vir Biotechnology</b>(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/488a166201699c1f3d6536aa3e640ecf\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"/><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><b>A safe harbor in stormy weather</b></p><p><b>George Budwell(Pfizer):</b>Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.</p><p>What&#39;s more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.</p><p>But less than three weeks out from the drug&#39;s initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.</p><p>What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.</p><p>So, if you&#39;re looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.</p><p><b>Revenue forecasts for Novavax:  $2 billion to $8 billion</b></p><p><b>Taylor Carmichael(Novavax):</b>Novavax is on the verge of greatness this year. The company&#39;s stock price is down to $125 a share. That&#39;s where it started in 2021, so last year was pretty much a washout for the stock.</p><p>Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.</p><p>Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it&#39;s highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company&#39;s already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.</p><p>Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that&#39;s over $4 billion in sales, just in Europe.</p><p>Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company&#39;s market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.</p><p><b>The antibody market all to itself</b></p><p><b>Patrick Bafuma(Vir Biotechnology):</b>The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from <b>Eli Lilly</b> (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from <b>Roche</b>and<b>Regeneron</b> are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--<b>GlaxoSmithKline</b> and Vir Biotechnology&#39;s sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it&#39;s the only one left right now to fight the omicron variant.</p><p>Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly&#39;s antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.</p><p>And while Pfizer&#39;s Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who&#39;s who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid&#39;s possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 COVID Stocks That Will Make Billions in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 COVID Stocks That Will Make Billions in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-08 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VIR":"Vir Biotechnology, Inc.","NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞"},"source_url":"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134509683","content_text":"It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.Pfizer(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy Novavax(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in Vir Biotechnology(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.IMAGE SOURCE: GETTY IMAGES.A safe harbor in stormy weatherGeorge Budwell(Pfizer):Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.What's more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.But less than three weeks out from the drug's initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.So, if you're looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.Revenue forecasts for Novavax:  $2 billion to $8 billionTaylor Carmichael(Novavax):Novavax is on the verge of greatness this year. The company's stock price is down to $125 a share. That's where it started in 2021, so last year was pretty much a washout for the stock.Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it's highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company's already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that's over $4 billion in sales, just in Europe.Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company's market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.The antibody market all to itselfPatrick Bafuma(Vir Biotechnology):The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from Eli Lilly (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from RocheandRegeneron are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--GlaxoSmithKline and Vir Biotechnology's sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it's the only one left right now to fight the omicron variant.Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly's antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.And while Pfizer's Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who's who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid's possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.","news_type":1,"symbols_score_info":{"PFE":0.9,"NVAX":0.9,"VIR":0.9}},"isVote":1,"tweetType":1,"viewCount":1250,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9031088194,"gmtCreate":1646386095759,"gmtModify":1676534124560,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087548065759240","idStr":"4087548065759240"},"themes":[],"htmlText":"🤢","listText":"🤢","text":"🤢","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031088194","repostId":"1137656968","repostType":2,"repost":{"id":"1137656968","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1646385222,"share":"https://ttm.financial/m/news/1137656968?lang=en_US&edition=fundamental","pubTime":"2022-03-04 17:13","market":"us","language":"en","title":"EV Stocks Slid in Premarket Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1137656968","media":"Tiger Newspress","summary":"EV stocks slid in premarket trading. Tesla, Nio, XPeng and LI Auto fell between 1% and 3%.","content":"<html><head></head><body><p>EV stocks slid in premarket trading. Tesla, Nio, XPeng and LI Auto fell between 1% and 3%.</p><p><img src=\"https://static.tigerbbs.com/34d7d51a8e654465a0c9ff00ac2cf761\" tg-width=\"411\" tg-height=\"361\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EV Stocks Slid in Premarket Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEV Stocks Slid in Premarket Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-03-04 17:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>EV stocks slid in premarket trading. Tesla, Nio, XPeng and LI Auto fell between 1% and 3%.</p><p><img src=\"https://static.tigerbbs.com/34d7d51a8e654465a0c9ff00ac2cf761\" tg-width=\"411\" tg-height=\"361\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来","TSLA":"特斯拉","XPEV":"小鹏汽车"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137656968","content_text":"EV stocks slid in premarket trading. Tesla, Nio, XPeng and LI Auto fell between 1% and 3%.","news_type":1,"symbols_score_info":{"TSLA":0.9,"NIO":0.9,"XPEV":0.9}},"isVote":1,"tweetType":1,"viewCount":964,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":475611224379424,"gmtCreate":1757143487275,"gmtModify":1757143490183,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087548065759240","idStr":"4087548065759240"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> b","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$&nbsp;</a> b","text":"$NVIDIA(NVDA)$ b","images":[{"img":"https://community-static.tradeup.com/news/61cf5a2bd17dc51e6a60fa4ce7e5f122","width":"972","height":"1631"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":1,"link":"https://ttm.financial/post/475611224379424","isVote":1,"tweetType":1,"viewCount":736,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9903868208,"gmtCreate":1659005176104,"gmtModify":1676536242569,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087548065759240","idStr":"4087548065759240"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>Ok","listText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>Ok","text":"$Apple(AAPL)$Ok","images":[{"img":"https://community-static.tradeup.com/news/8ec8f2e87af71ef48a0eb2212406d5a1","width":"828","height":"2125"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9903868208","isVote":1,"tweetType":1,"viewCount":589,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4113904591642392","authorId":"4113904591642392","name":"LMSunshine","avatar":"https://community-static.tradeup.com/news/0ad636f2490d8428fcee9da6d669e46c","crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"4113904591642392","idStr":"4113904591642392"},"content":"Thanks for leaving a comment in my post, appreciate it loads 🤗 Do check out other posts on my homepage & please help to like all my July posts if possible, many thanks","text":"Thanks for leaving a comment in my post, appreciate it loads 🤗 Do check out other posts on my homepage & please help to like all my July posts if possible, many thanks","html":"Thanks for leaving a comment in my post, appreciate it loads 🤗 Do check out other posts on my homepage & please help to like all my July posts if possible, many thanks"},{"author":{"id":"4113904591642392","authorId":"4113904591642392","name":"LMSunshine","avatar":"https://community-static.tradeup.com/news/0ad636f2490d8428fcee9da6d669e46c","crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"4113904591642392","idStr":"4113904591642392"},"content":"Are you new to Tiger?If yes,🥳welcome to the Tiger Community.I can’t follow more people as my app keeps crashing.If you follow me,I can check your homepage regularly & help to like your posts too!","text":"Are you new to Tiger?If yes,🥳welcome to the Tiger Community.I can’t follow more people as my app keeps crashing.If you follow me,I can check your homepage regularly & help to like your posts too!","html":"Are you new to Tiger?If yes,🥳welcome to the Tiger Community.I can’t follow more people as my app keeps crashing.If you follow me,I can check your homepage regularly & help to like your posts too!"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9023472959,"gmtCreate":1652955959771,"gmtModify":1676535195835,"author":{"id":"4087548065759240","authorId":"4087548065759240","name":"Jjsh","avatar":"https://static.tigerbbs.com/d1087a2f1627012e61324912c9a8c0e6","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087548065759240","idStr":"4087548065759240"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a>Ok","listText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a>Ok","text":"$Tiger Brokers(TIGR)$Ok","images":[{"img":"https://community-static.tradeup.com/news/4739cb322d76babc65bc0bc837e01032","width":"750","height":"1762"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9023472959","isVote":1,"tweetType":1,"viewCount":596,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}